Sherine E. Gabriel

Active 1988–2020

Also published as
Sherine E Gabriel
100
Papers
51,501
Citations
87
h-index
100
i10-index

Citations

Citations per year for Sherine E. Gabriel1971: 1 citations1978: 8 citations1987: 2 citations1991: 1 citations1992: 3 citations1993: 7 citations1994: 13 citations1995: 15 citations1996: 25 citations1997: 36 citations1998: 38 citations1999: 38 citations2000: 67 citations2001: 66 citations2002: 116 citations2003: 135 citations2004: 149 citations2005: 180 citations2006: 195 citations2007: 241 citations2008: 287 citations2009: 338 citations2010: 423 citations2011: 330 citations2012: 437 citations2013: 547 citations2014: 707 citations2015: 687 citations2016: 609 citations2017: 530 citations2018: 412 citations2019: 1,601 citations2020: 1,492 citations2021: 1,302 citations2022: 859 citations2023: 531 citations2024: 826 citations2025: 289 citations2026: 7 citations1972–1977: no citations, so these years are not shown1979–1986: no citations, so these years are not shown1988–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,694 citing papers, 23.6% of this breakdownUnited Kingdom: 1,740 citing papers, 8.7% of this breakdownChina: 1,409 citing papers, 7.1% of this breakdownCanada: 875 citing papers, 4.4% of this breakdownGermany: 747 citing papers, 3.7% of this breakdownAustralia: 729 citing papers, 3.7% of this breakdownItaly: 723 citing papers, 3.6% of this breakdownNetherlands: 575 citing papers, 2.9% of this breakdownFrance: 574 citing papers, 2.9% of this breakdownSpain: 561 citing papers, 2.8% of this breakdownSweden: 430 citing papers, 2.2% of this breakdownJapan: 387 citing papers, 1.9% of this breakdown
0%23.6%Other 32.5%

Fields

  • Medicine78.9%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology4.2%
  • Health Professions1.8%
  • Engineering1%
  • Neuroscience1%
  • Other6.6%

Topics

  • Rheumatoid Arthritis Research and Therapies7.9%
  • Osteoarthritis Treatment and Mechanisms3%
  • Systemic Lupus Erythematosus Research2.8%
  • Spondyloarthritis Studies and Treatments2.3%
  • Vasculitis and related conditions1.6%
  • Autoimmune and Inflammatory Disorders Research1.5%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Burch, Peter Burney, Jonathan R. Carapetis, Honglei Chen, David Chou, Sumeet S. Chugh, Luc E. Coffeng, Steven D Colan, Samantha Colquhoun, K. Ellicott Colson, John R. Condon, Myles Connor, Leslie T. Cooper, Matthew Corriere, Monica Cortinovis, Karen Courville de Vaccaro, William Couser, Benjamin C Cowie, Michael H Criqui, Marita Cross, Kaustubh Dabhadkar, Nabila Dahodwala, Diego De Leo, Louisa Degenhardt, Allyne Delossantos, Julie O. Denenberg, Don C. Des Jarlais, Samath Dhamminda Dharmaratne, E. Ray Dorsey, Tim Driscoll, Herbert C. Duber, Beth E. Ebel, Patricia J. Erwin, Patricia Espindola, Majid Ezzati, Valery L. Feigin, Abraham D Flaxman, Mohammad H. Forouzanfar, F.G.R. Fowkes, Richard C. Franklin, Marlene Fransen, Michael K Freeman, Sherine E. Gabriel, Emmanuela Gakidou, Flavio Gaspari, Richard F Gillum, Diego González-Medina, Yara A. Halasa, Diana Haring, James Harrison, Rasmus Havmoeller, Roderick J. Hay, Bruno Hoen, Peter J. Hotez, Damian Hoy, Kathryn H. Jacobsen, Spencer L James, Rashmi Jasrasaria, Sudha Jayaraman, Nicole E. Johns, Ganesan Karthikeyan, Nicholas J Kassebaum, Andre Keren, Jon‐Paul Khoo, Lisa Marie Knowlton, Olive Kobusingye, Adofo Koranteng, Rita Krishnamurthi, Michael S. Lipnick, Steven E. Lipshultz and 91 more - The Lancet 2012 cited by 14,264

  2. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II

    Authors: , , , , , , , , , , , , , , - Arthritis & Rheumatism 2007 cited by 5,528

  3. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study

    Authors: , , , , , , , , - Arthritis & Rheumatism 2010 cited by 860

  4. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

    Authors: , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 1,154

  5. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 233

  6. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007

    Authors: , , , , - Arthritis & Rheumatism 2010 cited by 804

  7. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

    Authors: , , , , , , , , , , , , , - Arthritis & Rheumatism 2007 cited by 2,077

  8. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2011 cited by 585

  9. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2010 cited by 647

  10. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

    Authors: , - Arthritis Research & Therapy 2009 cited by 902

  11. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population‐based study

    Authors: , , , , , - Arthritis Care & Research 2009 cited by 599

  12. Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes

    Authors: , , , , - Arthritis Care & Research 2003 cited by 605

  13. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based study

    Authors: , , , , - Arthritis & Rheumatism 2002 cited by 1,231

  14. Mortality, Disability, and Nursing Home Use for Persons with and without Hip Fracture: A Population‐Based Study

    Authors: , , , , - Journal of the American Geriatrics Society 2002 cited by 698

  15. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 277

  16. THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS

    Authors: - Rheumatic Disease Clinics of North America 2001 cited by 786

  17. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort study

    Authors: , , , , , , - Arthritis & Rheumatism 2005 cited by 927

  18. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year period

    Authors: , , , , - Arthritis & Rheumatism 2002 cited by 480

  19. Rheumatoid arthritis and cardiovascular disease

    Authors: , , , , , , , - American Heart Journal 2013 cited by 354

  20. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

    Authors: , - Nature Reviews Rheumatology 2011 cited by 418

  21. Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis

    Authors: , , , , - The American Journal of Cardiology 2012 cited by 265

  22. Contribution of obesity to the rise in incidence of rheumatoid arthritis

    Authors: , , , - Arthritis Care & Research 2012 cited by 244

  23. The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years

    Authors: , , , , , , - Arthritis & Rheumatism 2005 cited by 481

  24. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 316